Fifty410 publishes compounded tirzepatide at $133 a month, which is among the lowest figures in this category, with no membership fee and free shipping. Two details behind that number change what it means.
The Price, and the Commitment Behind It
| Tier | Monthly | Actually paid as |
|---|---|---|
| Tirzepatide, starter | $133/mo | $399 for a 3-month supply |
| Tirzepatide, high dose | $183/mo | $549 for a 3-month supply |
| Semaglutide | Offered; price not published | |
The monthly figures are 3-month bundles divided by three. To pay $133 a month you commit $399 up front. That is not a monthly price; it is a quarterly price presented monthly.
This matters more for GLP-1s than for most subscriptions, because a meaningful proportion of people stop in the first weeks. Gastrointestinal side effects are common early, and some people find them intolerable — covered in our GI side effects guide. Prepaying a quarter means discovering that after you have paid for twelve weeks, with refund terms that are not published.
Credit where due on the rest: no membership fee, no separate consultation fee, free shipping, and a dose tier published rather than hidden. The $50 gap between starter and high dose is transparent, which is better than programmes that quote a starting-dose price and let the cost climb silently on titration.
What “FDA-Registered” Actually Means
Fifty410 describes its medication as prepared by “FDA-registered 503A & 503B pharmacies”. Registration is a listing requirement. It is not approval, and it involves no FDA evaluation of the medication for safety, effectiveness or quality.
The phrase does real work in marketing precisely because it sounds like the opposite. A reader scanning quickly sees “FDA” next to their medication and concludes something has been checked. Nothing about the compounded product has been.
The 503A and 503B distinction is genuine and worth knowing. 503B outsourcing facilities register with the FDA, must follow current Good Manufacturing Practices and are subject to FDA inspection — a meaningfully higher bar. 503A pharmaciescompound for individual patients and are primarily state-regulated, without cGMP requirements. Naming both together tells you nothing about which one made your vial. That is the question to ask.
And the compounded route itself now needs justifying: the shortage pathway closed when the FDA resolved the tirzepatide shortage in October 2024 and the semaglutide shortage on 21 February 2025. See our compounded versus brand-name guide.
Buy Now, Pay Later on a Prescription
Fifty410 offers Afterpay and Affirm. On one reading this is straightforwardly good: it makes a $399 up-front cost manageable for someone who cannot absorb it in one month, and financing medication is not inherently worse than financing anything else.
The reason to flag it is the interaction with the quarterly commitment. Financing a three-month prepayment for a drug you have not tried means that if you stop in week three, you may still be making payments on medication you are no longer taking, on refund terms the site does not publish. Take the monthly option first if there is one, and establish the refund policy before financing anything.
Provider Facts
| Medications offered | Compounded tirzepatide and compounded semaglutide |
|---|---|
| Brand-name or compounded | Compounded, not FDA-approved as finished products. The company describes its pharmacies as FDA-registered 503A and 503B facilities - registration is not approval |
| Consultation process | Included in the treatment cost; no separate consultation fee. Format not published |
| Eligibility | Not published - no BMI threshold stated |
| Provider involvement | Licensed provider oversight, personalised dosing protocol, secure messaging with a care team, prescription management via patient portal |
| Lab requirements | Not published |
| Pharmacy fulfillment | Independent FDA-registered compounding pharmacies, described as 503A and 503B; individual pharmacies not named |
| Shipping frequency | Free; medications ship within 1 to 2 days |
| Support services | Secure messaging with the care team; no structured coaching programme described |
| Membership fees | None required |
| Medication fees | Tirzepatide $133/month starter ($399 per 3-month supply) and $183/month high dose ($549 per 3-month supply). Semaglutide price not published |
| Cancellation policy | Not published - the site directs to a separate refund policy page |
| Refund policy | Not published |
| Insurance | Does not bill insurance directly |
| HSA/FSA | Accepts FSA and HSA cards, plus major credit cards, Afterpay and Affirm |
| Availability | Not published - states served are not listed |
Pros and Cons
Pros
- $133/month tirzepatide is at the low end of the compounded market
- No membership fee and no separate consultation fee
- Dose tiers published, so titration cost is not a surprise
- Free shipping, dispatched in 1 to 2 days
- FSA/HSA cards accepted
- Secure messaging with a care team included
Cons
- The monthly price requires a 3-month prepayment
- “FDA-registered” is not FDA approval of the medication
- Does not say whether your vial comes from a 503A or a 503B facility
- Semaglutide pricing not published
- No eligibility criteria, states served or lab requirements published
- Refund and cancellation terms not published
- BNPL financing on a prepaid, untried medication
Who It May Be Best For
Potentially suitable if you have already tolerated tirzepatide, know it suits you, and want the lowest published compounded price with no membership stacked on top. For a continuing patient the quarterly commitment is much less of a risk than it is for a beginner.
Ask before paying: whether your medication comes from a 503A or 503B facility, what the refund policy is if you stop mid-quarter, whether a monthly option exists, and which states are served.
Less suitable if this is your first GLP-1. Prepaying twelve weeks before you know how you tolerate it is the wrong shape of risk.
Alternatives
Zappy Health publishes brand-name Wegovy pills from $149 with no membership — an FDA-approved product at a comparable price. Our cheapest GLP-1 programs page ranks by published price and flags commitment terms, and best tirzepatide providers covers the tirzepatide field specifically.
Limitations of This Review
Based on Fifty410’s published pages checked on 8 August 2026. We did not complete an intake or purchase. We could not establish semaglutide pricing, eligibility criteria, lab requirements, states served, which specific pharmacies dispense, whether a true monthly billing option exists alongside the 3-month bundles, or the detail of refund and cancellation terms, and we found no independent review record. The description of 503A and 503B regulation reflects published regulatory sources, not statements by the company. Nothing here is medical advice.
Frequently Asked Questions
Is it really $133 a month?
Only if you buy a 3-month supply for $399 up front. The monthly figure is the bundle divided by three, not a monthly billing option we could confirm.
Does “FDA-registered pharmacy” mean the drug is FDA-approved?
No. Registration is a listing requirement with no evaluation of the medication attached. Compounded GLP-1s are not FDA-approved as finished products regardless of where they are made.
What is the difference between 503A and 503B?
503B outsourcing facilities register with the FDA, must follow current Good Manufacturing Practices and are subject to FDA inspection. 503A pharmacies compound for individual patients and are primarily state-regulated without cGMP requirements. Ask which one made your vial.
Can I use HSA or FSA?
Yes — the site accepts FSA and HSA cards, along with credit cards and Afterpay or Affirm financing. It does not bill insurance directly.
Verdict
3.0 / 5
Genuinely low pricing with dose tiers published and no membership fee — undercut by a monthly figure that is really a quarterly prepayment, and an “FDA-registered” framing that implies an approval that does not exist.
The transferable lesson is the phrase. “FDA-registered facility” will appear on a great many products you look at, and it means the facility filed paperwork — not that anyone evaluated what is in the vial. Ask whether it is 503A or 503B, and you will learn more in one question than the marketing tells you in a page.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Fifty410's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: August 8, 2026